Acute Phase Reaction After First Neridronate Infusion in Children with Osteogenesis Imperfecta: An Analysis Based on Questionnaire Data from 65 Patients
Fever and skeletal pain are common yet self-limiting side effects after first neridronate infusion in children with OI. Adequate pain medication and caregiver education are important to improve treatment adherence and patient comfort during initiation of bisphosphonate therapy.
Authors
- Eva Nüsken (ORCID: https://orcid.org/0000-0002-0674-804X)
- Susanna Reincke (ORCID: https://orcid.org/0000-0003-2286-5761)
- Mirko Rehberg (ORCID: https://orcid.org/0000-0001-9534-4102)
- Stefanie Stasek (ORCID: https://orcid.org/0009-0009-0195-9428)
- Semler Oliver
- Heike Hoyer-Kuhn
- Felicitas Haselwarter
- Kristina Eva Rehberg
Institutions
- 82th Hospital of Pla (CN)
- University Hospital Cologne (DE)
Publication Details
- Journal
- Pediatric Drugs
- Published
- 2026-02-15
- DOI
- https://doi.org/10.1007/s40272-026-00737-6
- Primary Topic
- Connective tissue disorders research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Deutsche Forschungsgemeinschaft
- Universität zu Köln